Literature DB >> 33280001

Association of Maternal-Neonatal Steroids With Early Pregnancy Endocrine Disrupting Chemicals and Pregnancy Outcomes.

Margaret Banker1, Muraly Puttabyatappa2, Patrick O'Day3, Jaclyn M Goodrich4, Angela S Kelley5, Steven E Domino5, Yolanda R Smith5, Dana C Dolinoy4,6, Peter X K Song1, Richard J Auchus3, Vasantha Padmanabhan2,4,5,6.   

Abstract

CONTEXT: Steroids play an important role in fetal development and parturition. Gestational exposures to endocrine-disrupting chemicals (EDCs) affect steroidal milieu and pregnancy outcomes, raising the possibility of steroids serving as biomarkers. Most studies have not addressed the impact of EDC mixtures, which are reflective of real life scenarios.
OBJECTIVE: Assess the association of maternal and neonatal steroids with pregnancy outcomes and early pregnancy EDC levels.
DESIGN: Prospective analysis of mother-infant dyads.
SETTING: University hospital. PARTICIPANTS: 121 mother-infant dyads. MAIN OUTCOME MEASURES: The associations of maternal and neonatal steroidal hormones from 121 dyads with pregnancy outcomes, the associations of first trimester EDCs individually and as mixtures with maternal and neonatal steroids in a subset of 56 dyads and the influence of body mass index (BMI), age, and offspring sex in modulating the EDC associations with steroids were determined.
RESULTS: Steroid-specific positive or negative associations with pregnancy measures were evident; many maternal first trimester EDCs were negatively associated with estrogens and positively with androgen/estrogen ratios; EDC-steroid associations were influenced by maternal age, pre-pregnancy BMI, and fetal sex; and EDCs individually and as mixtures showed direct and inverse fetal sex-dependent associations with maternal and neonatal steroids.
CONCLUSIONS: This proof-of-concept study indicates association of steroids with pregnancy outcomes depending on maternal age, prepregnancy BMI, and fetal sex, with the effects of EDCs differing when considered individually or as mixtures. These findings suggest that steroidal hormonal measures have potential to serve as biomarkers of impact of EDC exposures and pregnancy outcome.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  developmental programming; endocrine disrupting chemical; estradiol; pregnancy; steroids; testosterone

Mesh:

Substances:

Year:  2021        PMID: 33280001      PMCID: PMC7947779          DOI: 10.1210/clinem/dgaa909

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  106 in total

1.  Maternal phthalate exposure during early pregnancy and at delivery in relation to gestational age and size at birth: A preliminary analysis.

Authors:  Deborah J Watkins; Samantha Milewski; Steven E Domino; John D Meeker; Vasantha Padmanabhan
Journal:  Reprod Toxicol       Date:  2016-06-25       Impact factor: 3.143

Review 2.  Glucocorticoids and fetal programming part 1: Outcomes.

Authors:  Vasilis G Moisiadis; Stephen G Matthews
Journal:  Nat Rev Endocrinol       Date:  2014-05-27       Impact factor: 43.330

3.  Ecological momentary assessment of maternal cortisol profiles over a multiple-day period predicts the length of human gestation.

Authors:  Sonja Entringer; Claudia Buss; Judith Andersen; Aleksandra Chicz-DeMet; Pathik D Wadhwa
Journal:  Psychosom Med       Date:  2011-06-23       Impact factor: 4.312

4.  Repeated Measurements of Paraben Exposure during Pregnancy in Relation to Fetal and Early Childhood Growth.

Authors:  Chuansha Wu; Wei Xia; Yuanyuan Li; Jiufeng Li; Bin Zhang; Tongzhang Zheng; Aifen Zhou; Hongzhi Zhao; Wenqian Huo; Jie Hu; Minmin Jiang; Chen Hu; Jiaqiang Liao; Xi Chen; Bing Xu; Shi Lu; Zongwei Cai; Shunqing Xu
Journal:  Environ Sci Technol       Date:  2018-12-11       Impact factor: 9.028

5.  Sex-specific associations of maternal prenatal testosterone levels with birth weight and weight gain in infancy.

Authors:  K M Voegtline; K A Costigan; K T Kivlighan; J L Henderson; J A DiPietro
Journal:  J Dev Orig Health Dis       Date:  2013-08       Impact factor: 2.401

6.  Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood.

Authors:  N Orentreich; J L Brind; R L Rizer; J H Vogelman
Journal:  J Clin Endocrinol Metab       Date:  1984-09       Impact factor: 5.958

7.  Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization.

Authors:  T Sir-Petermann; M Maliqueo; B Angel; H E Lara; F Pérez-Bravo; S E Recabarren
Journal:  Hum Reprod       Date:  2002-10       Impact factor: 6.918

Review 8.  Regulation of the adrenal androgen biosynthesis.

Authors:  William E Rainey; Yasuhiro Nakamura
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-11       Impact factor: 4.292

9.  Early metabolic derangements in daughters of women with polycystic ovary syndrome.

Authors:  Teresa Sir-Petermann; Manuel Maliqueo; Ethel Codner; Bárbara Echiburú; Nicolás Crisosto; Virginia Pérez; Francisco Pérez-Bravo; Fernando Cassorla
Journal:  J Clin Endocrinol Metab       Date:  2007-09-11       Impact factor: 5.958

10.  Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period.

Authors:  Elizabeth Ann L Enninga; Wendy K Nevala; Douglas J Creedon; Svetomir N Markovic; Shernan G Holtan
Journal:  Am J Reprod Immunol       Date:  2014-08-04       Impact factor: 3.886

View more
  5 in total

1.  Maternal 11-Ketoandrostenedione Rises Through Normal Pregnancy and Is the Dominant 11-Oxygenated Androgen in Cord Blood.

Authors:  Xin He; Margaret Banker; Muraly Puttabyatappa; Vasantha Padmanabhan; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

2.  Association of Maternal-Neonatal Steroids With Early Pregnancy Endocrine Disrupting Chemicals and Pregnancy Outcomes.

Authors:  Margaret Banker; Muraly Puttabyatappa; Patrick O'Day; Jaclyn M Goodrich; Angela S Kelley; Steven E Domino; Yolanda R Smith; Dana C Dolinoy; Peter X K Song; Richard J Auchus; Vasantha Padmanabhan
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

3.  Osteoblasts Generate Testosterone From DHEA and Activate Androgen Signaling in Prostate Cancer Cells.

Authors:  Henry H Moon; Katrina L Clines; Patrick J O'Day; Basel M Al-Barghouthi; Emily A Farber; Charles R Farber; Richard J Auchus; Gregory A Clines
Journal:  J Bone Miner Res       Date:  2021-05-18       Impact factor: 6.390

Review 4.  The Management of Pregnancy Complicated with the Previable Preterm and Preterm Premature Rupture of the Membranes: What about a Limit of Neonatal Viability?-A Review.

Authors:  Stepan Feduniw; Zuzanna Gaca; Olga Malinowska; Weronika Brunets; Magdalena Zgliczyńska; Marta Włodarczyk; Anna Wójcikiewicz; Michał Ciebiera
Journal:  Diagnostics (Basel)       Date:  2022-08-22

5.  Maternal phthalate and phthalate alternative metabolites and urinary biomarkers of estrogens and testosterones across pregnancy.

Authors:  Diana C Pacyga; Joseph C Gardiner; Jodi A Flaws; Zhong Li; Antonia M Calafat; Susan A Korrick; Susan L Schantz; Rita S Strakovsky
Journal:  Environ Int       Date:  2021-06-08       Impact factor: 13.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.